Company Filing History:
Years Active: 2009-2014
Title: Innovations of Tor Kihlberg in Radiopharmaceuticals
Introduction
Tor Kihlberg is a prominent inventor based in Uppsala, Sweden. He has made significant contributions to the field of radiopharmaceuticals, holding a total of nine patents. His work focuses on developing methods and reagents that enhance the efficiency and effectiveness of radiopharmaceuticals, particularly for use in medical imaging.
Latest Patents
Kihlberg's latest patents include innovative methods for miniaturized carboxylation using carbon-isotope labeled carbon dioxide. This process employs Grignard reagents or other organometallic reagents in a closable reaction loop or reactor. The resulting carbon-isotope labeled compounds are particularly useful as radiopharmaceuticals or precursors for radiopharmaceuticals, especially in Positron Emission Tomography (PET). Additionally, he has developed methods for photo-initiated carbonylation with carbon-isotope labeled carbon monoxide, utilizing amines and alkyl/aryl iodides. The resultant carbon-isotope labeled amides are also valuable for PET applications.
Career Highlights
Tor Kihlberg is associated with GE Healthcare Limited, where he continues to push the boundaries of innovation in the field of medical imaging. His work has been instrumental in advancing the capabilities of PET studies, providing essential tools for researchers and medical professionals.
Collaborations
Kihlberg has collaborated with notable colleagues such as Bengt Langstrom and Oleksiy Itsenko, contributing to a rich environment of innovation and research.
Conclusion
Tor Kihlberg's contributions to the field of radiopharmaceuticals exemplify the impact of innovative thinking in medical technology. His patents and ongoing work continue to shape the future of medical imaging and diagnostics.